SIEN - Sientra, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
10.32
-0.31 (-2.92%)
As of 12:33PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close 10.63
Open 10.60
Bid 10.30 x 1400
Ask 10.33 x 800
Day's Range 10.25 - 10.60
52 Week Range 8.79 - 26.79
Volume 318,653
Avg. Volume 490,672
Market Cap 295.145M
Beta (3Y Monthly) 1.30
PE Ratio (TTM) N/A
EPS (TTM) -3.29
Earnings Date May 4, 2017 - May 8, 2017
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 23.57
Trade prices are not sourced from all markets
  • GlobeNewswire 2 days ago

    Sientra to Present at the 8th Annual SVB Leerink Global Healthcare Conference

    SANTA BARBARA, Calif., Feb. 19, 2019 -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the.

  • What You Must Know About Sientra, Inc.’s (NASDAQ:SIEN) Financial Strength
    Simply Wall St. 8 days ago

    What You Must Know About Sientra, Inc.’s (NASDAQ:SIEN) Financial Strength

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Investors are always looking for growth inRead More...

  • GlobeNewswire 16 days ago

    Sientra Announces miraDry Leadership Transition

    Sientra, Inc. (SIEN), a medical aesthetics company, announced today that it has appointed Kirk Gunhus to the position of General Manager of miraDry, effective immediately. Mr. Gunhus succeeds Patrick Williams, who is leaving Sientra.

  • GlobeNewswire 20 days ago

    Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Sientra, Inc. (SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on January 31, 2019, the Compensation Committee of the Board of Directors approved equity award grants under the Sientra Inc. Inducement Plan to 39 new employees. The new employees were granted restricted stock units representing a total of 80,561 shares of common stock. The restricted stock units will vest in time-based installments beginning on the grant date.  In each case, the vesting of shares is contingent upon the recipient’s continued service with the Company through each vesting date.

  • GlobeNewswire last month

    Sientra Announces Preliminary Unaudited Fourth Quarter 2018 Net Sales and Appointment of Aesthetic Industry Veteran to Board of Directors

    Sientra, Inc. (SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced preliminary unaudited nets sales for the fourth quarter 2018. In addition, as previously disclosed, the Board of Directors of Sientra appointed Mary M. Fisher as a director of the Company effective January 1, 2019.

  • Is Sientra Inc (SIEN) A Good Stock To Buy?
    Insider Monkey 2 months ago

    Is Sientra Inc (SIEN) A Good Stock To Buy?

    “October lived up to its scary reputation—the S&P 500 falling in the month by the largest amount in the last 40 years, the only worse Octobers being ’08 and the Crash of ’87. For perspective, there have been only 5 occasions in those 40 years when the S&P 500 declined by greater than 20% from […]

  • Simply Wall St. 2 months ago

    How Much Did Sientra, Inc.’s (NASDAQ:SIEN) CEO Pocket Last Year?

    In 2015 Jeff Nugent was appointed CEO of Sientra, Inc. (NASDAQ:SIEN). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Then we'll look Read More...

  • GlobeNewswire 3 months ago

    New Research Coverage Highlights Phibro Animal Health, RadNet, Amphastar Pharmaceuticals, FibroGen, Sientra, and Flexion Therapeutics — Consolidated Revenues, Company Growth, and Expectations for 2018

    NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.

  • Implied Volatility Surging for Sientra (SIEN) Stock Options
    Zacks 3 months ago

    Implied Volatility Surging for Sientra (SIEN) Stock Options

    Investors need to pay close attention to Sientra (SIEN) stock based on the movements in the options market lately.

  • Thomson Reuters StreetEvents 3 months ago

    Edited Transcript of SIEN earnings conference call or presentation 6-Nov-18 9:30pm GMT

    Q3 2018 Sientra Inc Earnings Call

  • Sientra (SIEN) Reports Q3 Loss, Tops Revenue Estimates
    Zacks 4 months ago

    Sientra (SIEN) Reports Q3 Loss, Tops Revenue Estimates

    Sientra (SIEN) delivered earnings and revenue surprises of -7.46% and 3.74%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press 4 months ago

    Sientra: 3Q Earnings Snapshot

    The Santa Barbara, California-based company said it had a loss of 72 cents per share. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ...

  • PR Newswire 4 months ago

    Sientra Announces FULL CIRCLE Grant Recipients

    Eight Breast Cancer Nonprofits across the U.S. Selected to Receive Funding SANTA BARBARA, Calif. , Oct. 23, 2018 /PRNewswire/ -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, today announced ...

  • Are Options Traders Betting on a Big Move in Sientra (SIEN) Stock?
    Zacks 4 months ago

    Are Options Traders Betting on a Big Move in Sientra (SIEN) Stock?

    Investors need to pay close attention to Sientra (SIEN) stock based on the movements in the options market lately.

  • SEC sues U.S. breast-implant company's ex-CEO after stock dive
    Reuters 5 months ago

    SEC sues U.S. breast-implant company's ex-CEO after stock dive

    Hani Zeini, 54, was accused of letting the offering close on Sept. 23, 2015, despite having learned three days earlier from the chief executive of the company's sole supplier that European implant sales would be suspended because contamination had been detected in an audit of manufacturing procedures. Sientra's share price sank 52.9 percent on Sept. 24, 2015, to $9.70 from $20.58, after it disclosed that the U.K. Medicines and Healthcare Products Regulatory Agency had suspended the certificate needed for the supplier, Brazil's Silimed, to sell the implants. The SEC said Zeini had hid "damaging" details from "every other professional" working on his Santa Barbara, California-based company's 3 million share offering, including its chief financial officer, directors, lawyers, auditors and bankers, and tried to cover his tracks after it was done.

  • Reuters 5 months ago

    SEC sues ex-CEO of California breast implant company after stock nosedived

    The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering. Hani Zeini was accused of letting the offering close on Sept. 23, 2015, despite having learned three days earlier from the chief executive of the company's sole supplier that European implant sales would be suspended because contamination had been detected in an audit of manufacturing procedures. Sientra's share price sank 52.9 percent on Sept. 24, 2015, to $9.70 from $20.58, after it disclosed that the U.K. Medicines and Healthcare Products Regulatory Agency had suspended the certificate needed for the supplier, Brazil's Silimed, to sell the implants.

  • PR Newswire 6 months ago

    Sientra FULL CIRCLE™ Grant Applications Open to U.S. Breast Cancer Organizations

    SANTA BARBARA, Calif., Aug. 15, 2018 /PRNewswire/ -- Sientra, Inc. (SIEN), a medical aesthetics company, today announced that its FULL CIRCLE grant applications are now open for any U.S. based, nonprofit breast cancer organizations supporting breast cancer aid, research, patient outreach, advocacy, and prevention. The application period will end on September 15, 2018, and recipients will be announced by Sientra in October 2018. Sientra FULL CIRCLE™ is a first-of its-kind charitable program aimed at aiding nonprofits in the breast cancer community who are committed to making a meaningful difference.

  • Associated Press 7 months ago

    Sientra: 2Q Earnings Snapshot

    The Santa Barbara, California-based company said it had a loss of 73 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...